Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

ESC Highlights: MINOCA/ANOCA

Published:

30 September 2022

Citation:

European Cardiology Review 2022;17:e18.

Management of HF in Patients with CKD

Published:

26 July 2022

Citation:

European Cardiology Review 2022;17:e17.

APSC Consensus on OSA in CVD Patients

Published:

20 June 2022

Citation:

European Cardiology Review 2022;17:e16.

CVD in CKD: An Introduction

Published:

13 May 2022

Citation:

European Cardiology Review 2022;17:e13.